Targeting Polo-Like Kinase 1, a Regulator of P53, in the Treatment of Adrenocortical Carcinoma

Clinical and Translational Medicine - United Kingdom
doi 10.1186/s40169-015-0080-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Novel Treatment Strategy Targeting Polo-Like Kinase 1 in Hematological Malignancies

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Regulating a Key Mitotic Regulator, Polo-Like Kinase 1 (PLK1)

Cytoskeleton
Cell BiologyStructural Biology
2018English

Structural and Functional Analyses of Minimal Phosphopeptides Targeting the Polo-Box Domain of Polo-Like Kinase 1

Nature Structural and Molecular Biology
Structural BiologyMolecular Biology
2009English

A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas

Frontiers in Oncology
Cancer ResearchOncology
2019English

Polo-Like Kinase-1 as a Novel Target in Neoplastic Mast Cells: Demonstration of Growth-Inhibitory Effects of Small Interfering RNA and the Polo-Like Kinase-1 Targeting Drug BI 2536

Haematologica
Hematology
2011English

Myosin Phosphatase-Targeting Subunit 1 Regulates Mitosis by Antagonizing Polo-Like Kinase 1

Developmental Cell
BiochemistryDevelopmental BiologyGeneticsCell BiologyMolecular Biology
2008English

PLK1 (Polo-Like Kinase 1 (Drosophila))

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Role of Polo-Like Kinase in the Degradation of Early Mitotic Inhibitor 1, a Regulator of the Anaphase Promoting Complex/Cyclosome

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2004English

Polo-Like Kinase 1: A Novel Target for the Treatment of Therapy-Resistant Mantle Cell Lymphoma

Lymphoma
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy